AI assistant
ULTRALIFE CORP — Director's Dealing 2009
Nov 4, 2009
34105_dirs_2009-11-04_4bc55c9c-5194-4ece-a3e2-0957da42b542.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2009-11-02
Reporting Person: WHITMORE BRADFORD T (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-11-02 | Common Stock; $.10 par value | P | 26099 | $3.858 | Acquired | 154520 | Direct |
| 2009-11-03 | Common Stock; $.10 par value | P | 93858 | $4.157 | Acquired | 248378 | Direct |
| 2009-11-04 | Common Stock; $.10 par value | P | 75669 | $4.1148 | Acquired | 324047 | Direct |
Footnotes
F1: As general partner of Grace Brothers, Ltd., Bradford T. Whitmore is an indirect beneficial owner of 4,518,616 shares of Common Stock.
F2: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.769 to $4.01 inclusive. The reporting person undertakes to provide Ultralife Corporation, any security holder of Ultralife Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $4.03 to $4.19 inclusive. The reporting person undertakes to provide to Ultralife Corporation, any security holder of Ultralife Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (3) to this Form 4.
F4: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $4.10 to $4.14 inclusive. The reporting person undertakes to provifde to Ultralife Corporation, any security holder of Ultralife Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4.